BioSettia is a company that develops and commercializes technologies focused on life science research. It provides tools and specialty reagents to aid in genome-wide functional analysis and generation of induced pluripotent stem cells (iPSC). The company offers single-strand RNAi technology, microRNA expression systems, normalized full-length cDNA libraries, and lentiviral delivery systems.